Azitra, Inc. (NYSE American: AZTR), a leader in precision dermatology, has begun dosing the first patient in its Phase 1b trial of ATR-12 for Netherton syndrome. The trial will involve around 12 adult patients receiving twice-daily treatment for 14 days.…
BostonGene, a leader in AI-driven molecular and immune profiling, will showcase its advanced technologies at the 14th World Clinical Biomarkers & CDx Summit 2024, held from September 3 – 6 in Boston. The summit gathers professionals to advance biomarker-driven clinical…
Statistics & Data Corporation (SDC), a leader in life sciences biometrics and technology solutions, has introduced its innovative Bring Your Own Device (BYOD) electronic Patient Reported Outcomes (ePRO) solution. This new solution is set to revolutionize clinical trial processes. Statistics…
Modivcare Inc. (Nasdaq: MODV), a technology-driven healthcare services company, is teaming up with the American College of Cardiology (ACC) to launch the Caring Hearts Initiative in Camden County, New Jersey. This initiative, through Modivcare’s Higi service, aims to deliver crucial…
Repare Therapeutics Inc. (Nasdaq: RPTX), a clinical-stage precision oncology company, announced a strategic shift to prioritize the development of its clinical-stage oncology programs. The company will concentrate on advancing its key programs—lunresertib, camonsertib, RP-1664, and RP-3467—while significantly reducing its preclinical…
Research by THE SAGE GROUP analyzes the prevalence, characteristics, comorbidities, and outcomes of below-the-ankle (BTA) disease, while also exploring the challenges of endovascular revascularization. BTA (below-the-ankle) disease involves atherosclerotic stenoses or occlusions in foot arteries, including the pedal artery, plantar…
SoundHound AI, Inc. (Nasdaq: SOUN), a leader in voice artificial intelligence, announced that MUSC Health has launched an AI agent named Emily, powered by the Amelia Patient Engagement solution, to improve patient access and service. Emily, available 24/7, helps patients…
Delcath Systems, Inc. (Nasdaq: DCTH), a company specializing in interventional oncology for treating liver cancers, announced the publication of a clinical study in the journal Therapeutic Advances in Medical Oncology. The study, titled “Melanoma-specific survival of patients with uveal melanoma…
PatientPay, a top provider of patient billing and payments for acute, ambulatory, and specialty care, and ClearGage, known for its healthcare estimate and payment solutions, have completed their merger. The combined entity will now operate as PatientPay, offering an advanced…
Fresenius Kabi has introduced Cetrorelix Acetate for Injection, an FDA-approved, cost-effective generic option for women’s reproductive health. The kit, available immediately, includes one single-dose vial of 0.25 mg cetrorelix, a pre-filled syringe with 1 mL sterile water for injection, a…
